CME Group (CME) Beats Q3 Earnings and Revenue Estimates

Core Viewpoint - CME Group reported quarterly earnings of $2.68 per share, exceeding the Zacks Consensus Estimate of $2.63 per share, with earnings remaining unchanged from the previous year [1][2] Financial Performance - The earnings surprise for the quarter was +1.90%, and the company has surpassed consensus EPS estimates in all four of the last quarters [2] - CME posted revenues of $1.54 billion for the quarter ended September 2025, which was 0.81% above the Zacks Consensus Estimate, although it represents a decline from year-ago revenues of $1.58 billion [3] - The company has exceeded consensus revenue estimates three times in the last four quarters [3] Stock Performance - CME shares have increased approximately 15.7% since the beginning of the year, outperforming the S&P 500's gain of 14.5% [4] Future Outlook - The company's earnings outlook is crucial for investors, with current consensus EPS estimates for the upcoming quarter at $2.64 on revenues of $1.6 billion, and for the current fiscal year at $11.05 on revenues of $6.47 billion [8] - The estimate revisions trend for CME was unfavorable prior to the earnings release, resulting in a Zacks Rank 4 (Sell) for the stock, indicating expected underperformance in the near future [7] Industry Context - The Securities and Exchanges industry, to which CME belongs, is currently ranked in the bottom 30% of over 250 Zacks industries, suggesting potential challenges ahead [9]